Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

31
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
31
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

18
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

27
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
27
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

33
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
33
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

849
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
849
Flail Chest-II01:26

Flail Chest-II

225
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
225

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Risk factors of unfavorable clinical outcome in orbital granulomatosis with polyangiitis].

Vestnik oftalmologii·2026
Same author

[Laryngeal granulomas (literature review)].

Vestnik otorinolaringologii·2025
Same author

Isolated Antiphospholipid Syndrome Nephropathy (aPL Nephropathy)-A Rare Cause of a Rapid Decline in Kidney Function in a Patient With Systemic Lupus Erhythematosus.

Nephrology (Carlton, Vic.)·2025
Same author

[Potential of ultrasonography in determination of orbital inflammation activity in granulomatosis with polyangiitis].

Vestnik oftalmologii·2024
Same author

[Clinical and morphological correlations in patients with lupus nephritis: a retrospective study].

Terapevticheskii arkhiv·2024
Same author

[About the first publication of I.M. Sechenov. (To the 195th anniversary of his birth)].

Arkhiv patologii·2024

Related Experiment Video

Updated: Aug 24, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

497

[Pulmonary embolism and diffuse alveolar bleeding: combination options and therapy features].

A Y Tret'yakov1, S G Radenska-Lopovok2,3, P I Novikov2

  • 1Belgorod National Research University.

Terapevticheskii Arkhiv
|October 26, 2022
PubMed
Summary

This study examines rare cases of pulmonary embolism (PE) and diffuse alveolar hemorrhage (DAH) in systemic vasculitis. It proposes a classification and therapeutic strategies for these life-threatening complications.

Keywords:
capillaritisdiffuse alveolar bleedingexchange plasma transfusiongranulomatosis with polyangiitisimmunosuppressive therapyleukocytoclasisneutrophil recruitmentplasmapheresispulmonary embolismrecombinant coagulation factor VII

More Related Videos

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

426
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.1K

Related Experiment Videos

Last Updated: Aug 24, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

497
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

426
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.1K

Area of Science:

  • Rheumatology and Pulmonology
  • Pathophysiology of autoimmune diseases
  • Clinical diagnostics and treatment

Context:

  • Systemic vasculitis, including granulomatosis with polyangiitis, systemic lupus erythematosus, and antiphospholipid syndrome, can lead to severe complications.
  • Pulmonary embolism (PE) and diffuse alveolar hemorrhage (DAH) are rare but potentially fatal manifestations.
  • Understanding the interplay between PE and DAH is crucial for effective patient management.

Purpose:

  • To analyze the mechanisms behind the rare co-occurrence of PE and DAH in systemic vasculitis.
  • To review existing literature on this specific combination of complications.
  • To propose a working classification and therapeutic approach for PE and DAH.

Summary:

  • The study investigates the formation of PE and DAH in conditions like granulomatosis with polyangiitis and lupus erythematosus.
  • It considers three temporal patterns: DAH preceding PE, PE preceding DAH, or simultaneous onset.
  • A review of case reports, proposed criteria, and a severity classification are presented, alongside a modern therapeutic program.

Impact:

  • Provides a framework for diagnosing and classifying the combined PE and DAH in vasculitis patients.
  • Offers guidance for developing tailored treatment strategies for these critical conditions.
  • Aims to improve outcomes for patients experiencing these severe pulmonary complications.